Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery

• Status: Recruiting
• Trial end date: 2025-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The researchers are doing this study to find out whether giving methadone during spinal surgery helps manage pain in the first 72 hours after surgery better than other standard pain medications. Participants' pain will be measured by how much pain is reported after surgery, and how much additional pain medication is needed to lower pain levels. The researchers will look at whether giving methadone during surgery reduces the need for other pain medications after surgery. In addition, the team will compare the effects of methadone with the effects of a placebo to evaluate which one works best.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Memorial Sloan Kettering Cancer Center
• Treatments: Methadone

Criteria

Inclusion Criteria:

• Adult patients (between 18-75 years of age) scheduled for extradural spine surgery with instrumentation (greater than or equal to two levels and including minimally invasive) of expected duration ≥ 2 hours

• Postoperative hospital stay expected to be ≥ 2 nights at the time of consent

Exclusion Criteria:

• Use of methadone currently or within the previous 6 weeks

• Current use of a sustained-release or long-acting opioid

• Drug misuse history (e.g., ketamine, cocaine, heroin, amphetamine, methamphetamine, MDMA, phencyclidine, lysergic acid, mescaline, psilocybin).

• Current use of opioid antagonist/partial antagonist (i.e. buprenorphine).

• Current or past diagnosis of a Major Psychiatric disorder (such as Schizophrenia, dementia, delirium).

• Patients with a BMI ≥ 36 kg/m2

• 2nd or 3rd degree heart block as assessed by preoperative EKG.

• QTc > 450 msec on preoperative EKG.

• Documentation of congestive heart failure and/or ejection fraction < 30% if recorded in the Pre-Operative Record.

• Contraindication to use of any analgesic medications listed in the ERAS pathways (acetaminophen, gabapentin, celecoxib, IV opioids).

• Any known hypersensitivity to methadone.

• Pregnant or breastfeeding.

• Abnormal liver function tests as related to the MSK guidelines for use of IV acetaminophen: ALT greater than 2 x Upper Limit of Normal (> 75 U/L)

• Serum Creatinine > 1.5 mg/dl

• Instrumented spine cases of less than 2 levels

• All non-instrumented spine cases

• All intradural tumor resections

• All "take backs" that occur within 72 hours of surgery (wound revisions, hematomas, etc.)